Evidence map›Paper›PMID 28506784›Full record

Observational studyClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2018

Healthcare personnel intestinal colonization with multidrug-resistant organisms.

B K Decker, A F Lau, J P Dekker, C D Spalding, N Sinaii, S Conlan, D K Henderson, J A Segre, K M Frank, T N Palmore

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01952158 (Point Prevalence Study of Multidrug-Resistant Organism Carriage by Healthcare Personnel), which is not on this map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01952158 completednot on this map

Point Prevalence Study of Multidrug-Resistant Organism Carriage by Healthcare Personnel

TypeobservationalSponsorNational Institutes of Health Clinical Center (CC)Ran2013 to 2017Enrolled800ConditionsMultidrug Resistance
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Occupational Infection Risk with Multidrug-Resistant Organisms in Health Personnel-A Systematic Review.International journal of environmental research and public health · 2019
    Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. High carriage rate of extended-spectrum β-lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Antimicrobial agents and chemotherapy · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

B K DeckerNIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
A F LauNIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
J P DekkerNIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
C D SpaldingNIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
N SinaiiNIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
S ConlanNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
D K HendersonNIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
J A SegreNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
K M FrankNIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
T N PalmoreNIH Clinical Center, National Institutes of Health, Bethesda, MD, USA; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: tpalmore@mail.nih.gov.

Funding

Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial ResistanceZIAAI001249 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DEKKER, JOHN · 2019 to 2025
$13.7M
Microbial genomics of hospital-associated pathogensZIAHG200382 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SEGRE, JULIA ANGELA · 2012 to 2025
$9.1M
Environmental Surveillance for BacteriaZIACL010356 · CLC · CLINICAL CENTER · PI FRANK, KAREN · 2016 to 2021
$0k
Novel Diagnostic Platforms for Sterility Testing of Cellular Therapies and Biopharmaceutical ProductsZIACL060092 · CLC · CLINICAL CENTER · PI LAU, ANNA · 2014 to 2025
$0k
Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

objectivesThis study aims to assess the association between patient contact and intestinal carriage of multidrug-resistant organisms (MDRO) by sampling healthcare personnel (HCP) and staff without patient contact.

methodsFor this observational study, we recruited 400 HCP who worked in our 200-bed research hospital and 400 individuals without patient contact between November 2013 and February 2015. Participants submitted two self-collected perirectal swabs and a questionnaire. Swabs were processed for multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci (VRE). Questionnaires explored occupational and personal risk factors for MDRO carriage.

resultsAmong 800 participants, 94.4% (755/800) submitted at least one swab, and 91.4% (731/800) also submitted questionnaires. Extended spectrum β-lactamase-producing organisms were recovered from 3.4% (26/755) of participants, and only one carbapenemase-producing organism was recovered. No VRE were detected. The potential exposure of 68.9% (250/363) of HCP who reported caring for MDRO-colonized patients did not result in a rate of MDRO carriage among HCP (4.0%; 15/379) significantly higher than that of staff without patient contact (3.2%; 12/376; p 0.55).

conclusionsThis is the largest US study of HCP intestinal MDRO carriage. The low colonization rate is probably reflective of local community background rates, suggesting that HCP intestinal colonization plays a minor role in nosocomial spread of MDROs in a non-outbreak setting.

trial registrationclinicaltrials.gov Identifier: NCT01952158.

Indexed as

Health PersonnelAdultBacterial InfectionsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarrier StateCross InfectionDrug Resistance, Multiple, BacterialFemaleHumansIntestinesMaleMiddle AgedPrevalenceRisk FactorsBacterial Proteinsbeta-LactamasescarbapenemaseColonizationHealthcare personnelMultidrug-resistant organismOccupational exposurePerirectal sampling

Identifiers

PMID28506784
PMCPMC5682231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.